GELS

Gelteq Limited Ordinary Shares

There isn't enough reported data to score GELS yet.

GELS Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

GELS's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

GELS PE Valuation

GELS has no meaningful PE right now: it lost money over the past year.

GELS Forward outlook

There aren't enough analyst estimates for GELS to show an outlook.

GELS Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $0.38 on Nov 12.

There is not enough scenario data to assess GELS's risk to reward.

GELS Earnings Per Share

Q2 2025: $-0.49
Q2 2025: $-0.49

GELS Quarterly Revenue

Q2 2021: $0Q1 2022: --Q2 2022: $100,997Q1 2023: --Q2 2023: −$1Q1 2024: $0Q2 2024: $0Q4 2024: $4,556Q2 2025: $108,838
Q2 2021: $0Q1 2022: --Q2 2022: $100,997Q1 2023: --Q2 2023: −$1Q1 2024: $0Q2 2024: $0Q4 2024: $4,556Q2 2025: $108,838

GELS Free Cash Flow

Q2 2021: −$82,778Q1 2022: --Q2 2022: −$446,766Q1 2023: --Q2 2023: −$318,499Q1 2024: −$234,322Q2 2024: −$251,376Q4 2024: --Q2 2025: --
Q2 2021: −$82,778Q1 2022: --Q2 2022: −$446,766Q1 2023: --Q2 2023: −$318,499Q1 2024: −$234,322Q2 2024: −$251,376Q4 2024: --Q2 2025: --
QuarterFree cash flowYoY
Q2 2024-$251.4K+$67.1K
Q2 2023-$318.5K+$128.3K
Q2 2022-$446.8K-$364K

GELS Total Shares

Q2 2021: 9MQ2 2022: 9MQ2 2023: 0Q1 2024: 0Q4 2024: 9MQ2 2025: 9M
Q2 2021: 9MQ2 2022: 9MQ2 2023: 0Q1 2024: 0Q4 2024: 9MQ2 2025: 9M
PeriodChange %Net change
Quarterly+7.6%+652K shares

GELS has 9M diluted shares, down 1.8% from a year ago.

GELS Net Leverage

GELS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

GELS Weekly Momentum

MetricValueStatus
RSI39.9Neutral
Stochastic3.4Oversold

GELS's weekly RSI is 40 (neutral) and its Stochastic is 3 (oversold).

GELS PE vs Healthcare Sector

GELS has no meaningful PE right now: it lost money over the past year.

GELS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$0.4719% below
20 week MA$0.5632% below
50 week MA$0.6945% below
100 week MA$1.1567% below

GELS is in a downtrend: it's below all four of its weekly moving averages, and 67% below its 100-week average.

GELS Yearly ROI

YearStart priceEnd priceROI
2024$2.48$2.480%
2025$2.48$0.86-65%
2026 YTD$0.86$0.38-56%

GELS has finished every year since 2024 lower, and it's down 56% so far in 2026.

Give your agent the market.

Get API key